Telomir Pharmaceuticals, Inc. Common Stock

NASDAQ:TELO

Biotechnology

Healthcare
$0.69 -3.42%

-$0.04 today

Market cap
$50.84M
Beta
-0.24
P/E (TTM)
-3.8
EPS (TTM)
-$0.27
52W Low $0.89High $2.09

Volume 0.17M

Average 0.13M

TELO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How TELO compares with its peers on the latest reported figures

TELO Competitors Peer median
Gross Margin for TELO and competitors
Company Period LTM level YoY 3-year change
INMBINmune Bio, Inc.FY2025100.0% +0.0 pp+0.0 pp
KPTIKaryopharm Therapeutics Inc.LTM Mar 202696.0% -0.1 pp-0.8 pp
IPSCCentury Therapeutics, Inc.FY202588.0% -12.0 pp-12.0 pp
COEPCoeptis Therapeutics, Inc.LTM Mar 202687.2% +59.0 pp—
TELOTelomir Pharmaceuticals, Inc. Common StockFY2025— ——
EQEquillium, Inc.FY2025— ——
Peer median (excluding TELO) 92.0%-0.1 pp-0.8 pp

Competitors are the stored peer set for TELO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development126.49K833.21K1.57M2.24M2.44M
Selling, General & Admin11.64K20.94K600.19K9.64M8.1M
Operating Expenses138.13K854.15K3.94M12.24M10.54M
Depreciation & Amortization138.13K854.15K012.24M0
EBITDA00(11.43M)48K(10.41M)
EBITDA Margin—————
Operating Income(138.13K)(854.15K)(3.94M)(12.24M)(10.54M)
Operating Margin—————
Interest Income00048K125.64K
Interest Expense001.64M(4.34M)0
Other Income / Expenses00(9.13M)(4.29M)125.64K
Income Before Tax(138.13K)(854.15K)(13.07M)(16.53M)(10.41M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(138.13K)(854.15K)(13.07M)(16.53M)(10.41M)
Net Margin—————
EPS (Basic)(0.00)(0.03)(0.44)(0.56)(0.33)
EPS (Diluted)(0.00)(0.03)(0.44)(0.56)(0.33)
Weighted Avg Shares29.61M29.61M29.61M29.54M31.65M
Weighted Avg Shares (Diluted)29.61M29.61M29.61M29.54M31.65M

Telomir Pharmaceuticals, Inc. Common Stock

NASDAQ:TELO

Intrinsic Alpha fair value

Locked

Current Price

$0.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.